Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Medtronic
Julphar
Covington
Argus Health
Chubb

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,474,783

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,474,783
Title:HIP/PAP protein and derivatives thereof for use in treating cancer
Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
Inventor(s): Faivre; Jamila (Paris, FR), Vibert; Eric (Paris, FR), Darnaud; Marion (Paris, FR), Jamot; Laure (Paris, FR), Brechot; Christian (Paris, FR), Amouyal; Paul (Sevres, FR), Amouyal; Gilles (Paris, FR)
Assignee: ALFACT INNOVATION (Paris, FR) INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS SUD (Paris, FR)
Application Number:14/415,320
Patent Claims:see list of patent claims

Details for Patent 9,474,783

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Try a Free Trial ALFACT INNOVATION (Paris, FR) INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS SUD (Paris, FR) 2032-07-19 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial ALFACT INNOVATION (Paris, FR) INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS SUD (Paris, FR) 2032-07-19 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial ALFACT INNOVATION (Paris, FR) INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS SUD (Paris, FR) 2032-07-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
McKesson
US Department of Justice
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.